###begin article-title 0
Pten Dose Dictates Cancer Progression in the Prostate
###end article-title 0
###begin article-title 1
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
Dose of PTEN Gene Drives Progression of Prostate Cancer
###end article-title 1
###begin p 2
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 142 146 142 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 352 356 352 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 408 412 408 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 412 416 412 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/+</sup>
###xml 419 423 419 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 423 426 423 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 429 433 429 433 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 433 437 433 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 512 516 512 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 533 537 533 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 569 573 569 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 573 575 573 575 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc</sup>
###xml 657 661 657 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 661 663 661 663 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc</sup>
###xml 681 685 681 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 783 787 783 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 966 970 966 970 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 1056 1060 1056 1060 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 357 362 <span type="species:ncbi:10090">mouse</span>
Complete inactivation of the PTEN tumor suppressor gene is extremely common in advanced cancer, including prostate cancer (CaP). However, one PTEN allele is already lost in the vast majority of CaPs at presentation. To determine the consequence of PTEN dose variations on cancer progression, we have generated by homologous recombination a hypomorphic Pten mouse mutant series with decreasing Pten activity: Ptenhy/+ > Pten+/- > Ptenhy/- (mutants in which we have rescued the embryonic lethality due to complete Pten inactivation) > Pten prostate conditional knockout (Ptenpc) mutants. In addition, we have generated and comparatively analyzed two distinct Ptenpc mutants in which Pten is inactivated focally or throughout the entire prostatic epithelium. We find that the extent of Pten inactivation dictate in an exquisite dose-dependent fashion CaP progression, its incidence, latency, and biology. The dose of Pten affects key downstream targets such as Akt, p27Kip1, mTOR, and FOXO3. Our results provide conclusive genetic support for the notion that PTEN is haploinsufficient in tumor suppression and that its dose is a key determinant in cancer progression.
###end p 2
###begin p 3
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice with progressively decreasing amounts of the tumor suppressor PTEN demonstrate that this gene affects -- in an exquisite dose-dependent fashion -- prostate tumor incidence and progression
###end p 3
###begin title 4
Introduction
###end title 4
###begin p 5
###xml 4 8 4 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 313 317 313 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 390 411 390 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Cantley1">Cantley and Neel 1999</xref>
###xml 413 444 413 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Di1">Di Cristofano and Pandolfi 2000</xref>
###xml 157 162 <span type="species:ncbi:9606">human</span>
###xml 376 381 <span type="species:ncbi:9606">human</span>
The PTEN (phosphatase and tensin homolog deleted on chromosome 10) tumor suppressor gene is located on chromosome 10q23, a genomic region frequently lost in human cancers. Somatic deletions or mutations of this gene have been identified in a large fraction of tumors, frequently in prostate cancer (CaP), placing PTEN among the most commonly mutated tumor suppressor genes in human cancer (Cantley and Neel 1999; Di Cristofano and Pandolfi 2000).
###end p 5
###begin p 6
###xml 46 60 46 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Knudson1">(Knudson 1971)</xref>
###xml 119 123 119 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 219 223 219 223 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 319 323 319 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 436 440 436 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 527 531 527 531 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
As dictated by Knudson's "two-hit" hypothesis (Knudson 1971), however, the analysis of cancer samples for mutations in PTEN has been performed searching for biallelic inactivation of the gene, which pointed at complete PTEN inactivation as a late event in cancer progression. The consequence of loss or mutation in one PTEN allele in carcinomas in situ or in primary cancers may have been underestimated. It could be postulated that if PTEN were to be haploinsufficient for some of its tumor-suppressive functions, loss of one PTEN allele or reduction in its expression may be playing a key role in tumor initiation, while further reduction of its function/expression may favor invasion and possibly tumor metastasis in advanced cancers.
###end p 6
###begin p 7
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 166 182 166 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Gray1">Gray et al. 1998</xref>
###xml 184 201 184 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Whang1">Whang et al. 1998</xref>
###xml 237 241 237 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 303 324 303 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Cantley1">Cantley and Neel 1999</xref>
###xml 326 357 326 357 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Di1">Di Cristofano and Pandolfi 2000</xref>
###xml 407 411 407 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
In agreement with this hypothesis, it has been reported that primary tumors often show loss or alteration of at least one PTEN allele (e.g., 70%-80% of primary CaPs; Gray et al. 1998; Whang et al. 1998), while homozygous inactivation of PTEN is generally associated with advanced cancer and metastasis (Cantley and Neel 1999; Di Cristofano and Pandolfi 2000), supporting a possible key role for progressive PTEN functional loss in tumor progression.
###end p 7
###begin p 8
###xml 698 716 698 716 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Hemann1">Hemann et al. 2003</xref>
###xml 891 916 891 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Di2">Di Cristofano et al. 1998</xref>
###xml 918 923 918 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Di4">2001a</xref>
###xml 925 943 925 943 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Suzuki1">Suzuki et al. 1998</xref>
###xml 945 968 945 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Podsypanina1">Podsypanina et al. 1999</xref>
###xml 1117 1121 1117 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1276 1280 1276 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1402 1406 1402 1406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1556 1560 1556 1560 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 395 400 <span type="species:ncbi:10090">mouse</span>
###xml 925 931 <span type="species:ncbi:8164">Suzuki</span>
###xml 1353 1358 <span type="species:ncbi:9606">human</span>
###xml 1482 1487 <span type="species:ncbi:10090">mouse</span>
The elucidation of the molecular basis for tumor initiation and progression in most epithelial neoplasms has been hindered by the lack of suitable laboratory and preclinical models that accurately reflect the genetic and histopathological progression of these cancers. Furthermore, the outcome of a progressive dose reduction in tumor suppressor function has been rarely assessed in vivo in the mouse. Small interfering RNA (siRNA) technology has more recently allowed testing the consequence of knockdown of a tumor suppressor such as p53 in specific cell types such as hemopoietic stem cells, by generating epi-allelic series of hypomorphs created by stable RNA interference (RNAi) transduction (Hemann et al. 2003). In the case of Pten, this analysis is further complicated since complete inactivation of the gene results in early embryonic lethality and aberrant developmental programs (Di Cristofano et al. 1998, 2001a; Suzuki et al. 1998; Podsypanina et al. 1999). Thus, a further unrestricted reduction of the Pten dose could still result in embryonic lethality. On the other hand, the consequence of complete Pten inactivation, even when restricted to a specific organ/tissue, could still affect the developmental program of that organ, while complete somatic loss of Pten in an adult organ would better approximate what is normally observed in human cancer. We have addressed these issues for Pten, as we describe in this article, through the generation of (i) hypomorphic mouse mutants and (ii) conditional mutants for complete prostate-specific Pten inactivation after puberty.
###end p 8
###begin p 9
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 51 54 51 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 248 274 248 274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Di4">Di Cristofano et al. 2001a</xref>
###xml 277 281 277 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 281 284 281 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 386 390 386 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 390 393 390 393 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 397 401 397 401 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 394 401 394 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p27<sup>Kip1</sup></italic>
###xml 401 404 401 404 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 408 412 408 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 412 415 412 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 419 423 419 423 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 416 423 416 423 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p27<sup>Kip1</sup></italic>
###xml 423 426 423 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 434 436 434 436 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> (</bold>
###xml 436 462 436 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Di4">Di Cristofano et al. 2001a</xref>
###xml 737 741 737 741 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 741 744 741 744 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 754 758 754 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 762 766 762 766 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 759 766 759 766 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p27<sup>Kip1</sup></italic>
###xml 808 812 808 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1013 1017 1013 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1017 1020 1017 1020 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1198 1202 1198 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 745 749 <span type="species:ncbi:10090">mice</span>
We previously reported that Pten heterozygous (Pten+/-) mutants are prone to develop neoplasms of various histological origins, including prostatic intraepithelial neoplasias (PIN) after a long latency ( >14 mo) and at incomplete penetrance (40%) (Di Cristofano et al. 2001a). Pten+/- mutants, however, never develop invasive CaPs. Invasive CaPs were, by contrast, observed in compound Pten+/-/p27Kip1+/- or Pten+/-/p27Kip1-/- mutants (Di Cristofano et al. 2001a). These lesions appeared to originate in PIN lesions, which then become invasive. However, no metastatic CaP was observed in this model, also in view of early lethality due to the occurrence of concomitant tumors of various histogenesis. Analysis of tumors, PIN, and CaP in Pten+/- mice and Pten/p27Kip1 compound mutants strongly suggested that Pten may be haploinsufficient in prostate tumor suppression since Pten protein expression was never lost in these lesions. If this was indeed the case, a further reduction in the Pten dose with respect to Pten+/- mutants should impact on tumorigenesis and tumor progression. By contrast, in case Pten needed to be completely lost for phenotypic consequences to be manifest, only a complete Pten inactivation would hasten the neoplastic process.
###end p 9
###begin p 10
###xml 106 128 106 128 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Maehama1">Maehama and Dixon 1998</xref>
###xml 195 219 195 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Vivanco1">Vivanco and Sawyers 2002</xref>
###xml 576 597 576 597 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Stambolic1">Stambolic et al. 1998</xref>
###xml 599 624 599 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Di3">Di Cristofano et al. 1999</xref>
###xml 626 645 626 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Backman1">Backman et al. 2002</xref>
###xml 647 671 647 671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Vivanco1">Vivanco and Sawyers 2002</xref>
###xml 909 913 909 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
The discovery that phosphatidylinositol 3,4,5-trisphosphate (PIP3) is the main in vivo substrate of PTEN (Maehama and Dixon 1998) placed this phosphatase into a well-defined pathway (reviewed in Vivanco and Sawyers 2002). PIP3 levels are very low in quiescent cells, but rapidly increase upon stimulation by growth factors, through phosphoinositide 3-kinase (PI3K) activation. The role of PTEN is to keep the levels of PIP3 low by dephosphorylation at the D3 position. Loss of PTEN function results in increased PIP3 levels and subsequent Akt hyperactivation/phosphorylation (Stambolic et al. 1998; Di Cristofano et al. 1999; Backman et al. 2002; Vivanco and Sawyers 2002). It may therefore be proposed that a progressive reduction in the Pten dose could simply result in a concomitant progressive dose-dependent increase in Akt activation and its downstream molecular biological consequences. Alternatively, Pten expression levels may constitute discrete biochemical thresholds below which qualitative functional changes would occur, contributing to tumor progression and invasion.
###end p 10
###begin p 11
###xml 292 296 292 296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 362 378 362 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Gray1">Gray et al. 1998</xref>
###xml 380 397 380 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Whang1">Whang et al. 1998</xref>
###xml 399 430 399 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Di1">Di Cristofano and Pandolfi 2000</xref>
###xml 524 528 524 528 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 592 608 592 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Gray1">Gray et al. 1998</xref>
###xml 610 627 610 627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Whang1">Whang et al. 1998</xref>
###xml 220 228 <span type="species:ncbi:9606">patients</span>
CaP is the most common non-skin malignancy among Western adult males. It is estimated that in 2003, approximately 220,900 new cases and 28,900 CaP-related deaths will occur in the United States. Approximately 70% of CaP patients will harbor mutation or display loss of at least one allele of PTEN ensuing in the constitutive activation of the PI3K/mTOR pathway (Gray et al. 1998; Whang et al. 1998; Di Cristofano and Pandolfi 2000). As aforementioned, those mutations are in positive correlation with tumor stage and grade, PTEN being completely lost in approximately 40% of metastatic CaPs (Gray et al. 1998; Whang et al. 1998). We therefore decided to focus on the prostate as an important model system to determine genetically whether and how the dose of Pten dictates tumor initiation and progression.
###end p 11
###begin p 12
###xml 142 146 142 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 41 46 <span type="species:ncbi:10090">mouse</span>
We demonstrate in vivo, in a hypomorphic mouse mutant series, that Pten plays a crucial dose-dependent role in CaP tumor suppression and that Pten progressive inactivation leads to both quantitative and qualitative molecular and biological changes towards full-blown tumorigenesis.
###end p 12
###begin title 13
Results
###end title 13
###begin title 14
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
Generation of a Hypomorphic Pten Mutant Series
###end title 14
###begin p 15
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 152 177 152 177 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Di2">Di Cristofano et al. 1998</xref>
###xml 179 184 179 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Di4">2001a</xref>
###xml 334 338 334 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 338 341 338 341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 427 431 427 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 463 467 463 467 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 571 591 571 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-McDevitt1">McDevitt et al. 1997</xref>
###xml 593 611 593 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Morita1">Morita et al. 2003</xref>
###xml 643 647 643 647 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 731 739 731 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g001">Figure 1</xref>
###xml 751 759 751 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g003">Figure 3</xref>
###xml 913 917 913 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1063 1071 1063 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g003">Figure 3</xref>
###xml 1074 1099 1074 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">see Materials and Methods</xref>
###xml 1180 1184 1180 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1184 1186 1184 1186 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy</sup>
###xml 1300 1304 1300 1304 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1304 1308 1304 1308 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/+</sup>
###xml 1319 1323 1319 1323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1323 1326 1323 1326 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1366 1374 1366 1374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g001">Figure 1</xref>
###xml 239 244 <span type="species:ncbi:10090">mouse</span>
###xml 717 720 <span type="species:ncbi:12305?0.03296277145811789|species:ncbi:36410?3.8779731127197516E-4">CMV</span>
###xml 765 770 <span type="species:ncbi:10090">mouse</span>
###xml 1309 1313 <span type="species:ncbi:10090">mice</span>
###xml 1327 1331 <span type="species:ncbi:10090">mice</span>
We have previously reported that Pten heterozygous mutants are tumor prone and viable, while complete Pten inactivation results in embryonic lethality (Di Cristofano et al. 1998, 2001a). We therefore decided to generate and characterize a mouse mutant in which the dose of Pten would be reduced further below the levels observed in a Pten+/- mutant. To this end, we at first engineered by homologous recombination an allele of Pten that would express a wild-type Pten gene at reduced levels, taking advantage of the well-known phenomenon of transcriptional interference (McDevitt et al. 1997; Morita et al. 2003). We therefore targeted within Pten intron 3 the neomycin (Neo) cassette under the control of the strong CMV promoter (Figure 1A; see also Figure 3A) in mouse embryonic stem (ES) cells. Transcription of the Neo cassette in the recombined allele was expected to interfere with the transcription of the Pten gene, in turn resulting in lower expression levels of a wild-type Pten protein by this allele. Correctly recombined ES clones were obtained (see Figure 3B; see Materials and Methods) and injected into blastocysts for germline transmission. Mutants harboring the Ptenhy allele were obtained from recombined ES cells and were found viable, thriving, and fertile. We next intercrossed Ptenhy/+ mice with Pten+/- mice to generate a hypomorphic series (Figure 1B).
###end p 15
###begin title 16
###xml 41 45 41 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
Partial Rescue of Embryonic Lethality in Pten Hypomorphic Mutants
###end title 16
###begin p 17
###xml 122 126 122 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 126 130 126 130 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 182 183 182 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 215 219 215 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 219 223 219 223 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 352 356 352 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 356 360 356 360 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 456 460 456 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 460 464 460 464 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 486 490 486 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 490 494 490 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 613 617 613 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 617 621 617 621 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 756 760 756 760 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 760 764 760 764 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 861 865 861 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 865 869 865 869 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 1119 1123 1119 1123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1123 1127 1123 1127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 1153 1157 1153 1157 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1157 1160 1157 1160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1162 1166 1162 1166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1166 1170 1166 1170 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/+</sup>
###xml 1342 1350 1342 1350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g001">Figure 1</xref>
###xml 1353 1361 1353 1361 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g002">Figure 2</xref>
###xml 1367 1368 1367 1368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g002">2</xref>
###xml 1448 1452 1448 1452 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1472 1476 1472 1476 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1476 1480 1476 1480 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 1503 1507 1503 1507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1507 1510 1507 1510 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1536 1544 1536 1544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g001">Figure 1</xref>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 1226 1231 <span type="species:ncbi:10090">mouse</span>
The further reduction of the Pten dose could indeed result in embryonic lethality; we therefore assessed whether compound Ptenhy/- mice would be born at all. In the analyzed cohort (n = 190), viable male and female Ptenhy/- mutants were in fact obtained. However, the frequencies among various genotypes did not follow Mendelian ratios. Out of the 25% Ptenhy/- mutants expected in these crosses, only 10% were born. In particular, approximately 40% of the Ptenhy/- males and 75% of the Ptenhy/- females were lost during gestation. This strongly suggested that a further reduction of the Pten dose had occurred in Ptenhy/- mutants and that this reduction still results in embryonic lethality, albeit at incomplete penetrance (the embryonic phenotype of the Ptenhy/- will be described elsewhere; L. C. Trotman and P. P. Pandolfi, unpublished data). Enough viable Ptenhy/- males were obtained, however, and monitored for tumorigenesis in the prostate. As predicted, a significant reduction in Pten levels and the consequent increase in Akt activation (phospho-Akt/Akt ratio) were observed in organs and primary cells from Ptenhy/- mutants when compared to Pten+/-, Ptenhy/+, and wild-type littermates. In particular, we analyzed mouse embryonic fibroblasts (MEFs), peripheral blood mononuclear cells (PBMCs), and prostates of various genotypes (Figure 1C; Figure 2A and 2B; data not shown). Semiquantitative RT-PCR analysis confirmed the reduction of Pten mRNA expression in Ptenhy/- MEFs when compared to Pten+/- and wild-type cells (see Figure 1D).
###end p 17
###begin title 18
###xml 49 53 49 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 53 57 53 57 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
Massive Prostate Hyperplasia and Invasive CaP in Ptenhy/- Mutants
###end title 18
###begin p 19
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 73 77 73 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 114 118 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 118 122 118 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/+</sup>
###xml 128 132 128 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 132 135 132 135 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 142 150 142 150 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g002">Figure 2</xref>
###xml 156 157 156 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g002">2</xref>
###xml 205 209 205 209 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 209 213 209 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 223 231 223 231 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g002">Figure 2</xref>
###xml 299 303 299 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 303 307 303 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/+</sup>
###xml 309 310 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 318 322 318 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 322 325 322 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 327 328 327 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 353 354 353 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 385 411 385 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Di4">Di Cristofano et al. 2001a</xref>
###xml 418 422 418 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 422 426 422 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 428 429 428 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 679 704 679 704 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">see Materials and Methods</xref>
###xml 957 961 957 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 961 965 961 965 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 978 982 978 982 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 982 985 982 985 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1170 1174 1170 1174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1174 1177 1174 1177 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1182 1186 1182 1186 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1186 1189 1186 1189 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1249 1257 1249 1257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g002">Figure 2</xref>
###xml 1264 1272 1264 1272 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g005">Figure 5</xref>
###xml 1276 1280 1276 1280 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1280 1283 1280 1283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1486 1494 1486 1494 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g002">Figure 2</xref>
###xml 1497 1523 1497 1523 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Di4">Di Cristofano et al. 2001a</xref>
###xml 1610 1614 1610 1614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1614 1618 1614 1618 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 1742 1750 1742 1750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g005">Figure 5</xref>
###xml 1829 1837 1829 1837 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g002">Figure 2</xref>
###xml 1843 1844 1843 1844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g002">2</xref>
###xml 1961 1965 1961 1965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1965 1969 1965 1969 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 2106 2114 2106 2114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g002">Figure 2</xref>
###xml 2580 2580 2580 2580 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 2610 2614 2610 2614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 2614 2618 2614 2618 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 2740 2744 2740 2744 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 2744 2747 2744 2747 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 2783 2787 2783 2787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 2787 2790 2787 2790 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 2795 2799 2795 2799 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 2799 2802 2799 2802 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 2806 2810 2806 2810 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 2803 2810 2803 2810 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p27<sup>Kip1</sup></italic>
###xml 2810 2813 2810 2813 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2823 2849 2823 2849 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Di4">Di Cristofano et al. 2001a</xref>
###xml 2935 2939 2935 2939 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 2939 2943 2939 2943 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 3019 3023 3019 3023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 3032 3040 3032 3040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g002">Figure 2</xref>
###xml 3098 3102 3098 3102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 3102 3106 3102 3106 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 3295 3303 3295 3303 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g002">Figure 2</xref>
###xml 3310 3318 3310 3318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g005">Figure 5</xref>
###xml 3392 3396 3392 3396 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 3396 3400 3396 3400 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 3428 3432 3428 3432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 3432 3435 3432 3435 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 3643 3659 3643 3659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Park1">Park et al. 2001</xref>
###xml 136 140 <span type="species:ncbi:10090">mice</span>
###xml 468 472 <span type="species:ncbi:10090">Mice</span>
###xml 789 793 <span type="species:ncbi:10090">mice</span>
###xml 986 990 <span type="species:ncbi:10090">mice</span>
###xml 1190 1194 <span type="species:ncbi:10090">mice</span>
###xml 1650 1654 <span type="species:ncbi:10090">mice</span>
###xml 2314 2318 <span type="species:ncbi:10090">mice</span>
###xml 2619 2623 <span type="species:ncbi:10090">mice</span>
###xml 2748 2752 <span type="species:ncbi:10090">mice</span>
###xml 3107 3111 <span type="species:ncbi:10090">mice</span>
###xml 3637 3641 <span type="species:ncbi:10090">mice</span>
###xml 3693 3698 <span type="species:ncbi:10090">mouse</span>
The levels of Pten were indeed further reduced in the prostates from Ptenhy/- mutants when compared to wild-type, Ptenhy/+, and Pten+/- mice (Figure 2A and 2B). Conversely, Akt activation was increased in Ptenhy/- mutants (Figure 2B). On this premise, we therefore studied prostate tumorigenesis in Ptenhy/+ (n = 26), Pten+/- (n = 24 in this study plus n = 18, as previously reported; Di Cristofano et al. 2001a), and Ptenhy/- (n = 14) mutants on a comparative basis. Mice were followed throughout their lives according to the following experimental scheme: (i) all cohorts were subjected to serial monthly (in selected cases, biweekly) nuclear magnetic resonance imaging (MRI) (see Materials and Methods) for detection of morphological changes in the size and shape of the prostate; (ii) mice were sacrificed at or prior to tumor detection for postmortem pathological analysis or when manifest sign of distress were observed (owing to tumor codevelopment; Ptenhy/- mutants, as Pten+/- mice, in fact, developed tumors of multiple histologic origins; data not shown). Striking differences were observed in the prostates of these three cohorts over time. The prostates of Pten+/+ and Pten+/- mice were never found enlarged by MRI analysis at any age (Figure 2C; see Figure 5D). Pten+/- mutants developed moderate/low-grade PINs at incomplete penetrance (35%-40% approximately, after a long latency of >12 mo) that were only detected by serial postmortem analysis, as previously reported (Figure 2F; Di Cristofano et al. 2001a). Strikingly, however, MRI analysis immediately revealed a profound difference in the Ptenhy/- cohort. The prostates of these mice were found markedly enlarged, and prostate growths were detected starting at 3 mo (see Figure 5D). By 6-8 mo, these growths typically surpassed the size of seminal vesicles (Figure 2C and 2D). Interestingly, prostate enlargements were not accompanied by an overall increase in total body weight or size in Ptenhy/- mutants (data not shown). Postmortem pathological analysis of such mutants confirmed the marked epithelial hyperplasia of the prostate (Figure 2F). All lobes were found to be hypercellular, with prominent macroscopic enlargements of anterior and dorsolateral lobes. Microscopically, the regular and round prostatic glands observed in wild-type mice were replaced by large, irregular, and complex glands that contained multiple intraluminal papillary projections already at age 2-3 mo. Furthermore, many cells had sizeable nuclei, clumped chromatin, and prominent nucleoli, forming foci of epithelial dysplasia.The phenotype observed in the Ptenhy/- mice was characterized by a wide spectrum of levels of cellular differentiation, which was not typically observed in the Pten+/- mice. As we previously reported in Pten+/- and Pten+/-/p27Kip1-/- mutants (Di Cristofano et al. 2001a), Pten protein expression was also still retained in the hyperplastic prostates from Ptenhy/- mutants, and Southern blot analysis confirmed retention of the hypomorphic Pten allele (Figure 2E; data not shown). Importantly, approximately 25% of the Ptenhy/- mice analyzed at more than 6 mo of age showed histological signs of local invasion, with tumor cells disrupting the basement membrane of the gland and growing into the surrounding stroma (Figure 2F; see Figure 5E). Thus, strikingly, a further reduction in the Pten dose as observed in Ptenhy/- mutants when compared with Pten+/- mutants does lead to massive prostate hyperplasia at complete penetrance and accelerates tumor progression from high-grade PIN (grade 3-4 tumor as per the CaP grading system for genetically engineered mice; Park et al. 2001) to locally invasive CaP in this mouse model.
###end p 19
###begin title 20
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
Generation of Conditional Prostate-Specific Pten Mutants
###end title 20
###begin p 21
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 163 167 163 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 197 201 197 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP</italic>
###xml 209 217 209 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g003">Figure 3</xref>
###xml 220 245 220 245 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">see Materials and Methods</xref>
###xml 317 321 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 321 325 321 325 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/+</sup>
###xml 331 339 331 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EIIA-Cre</italic>
###xml 357 374 357 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Lakso1">Lakso et al. 1996</xref>
###xml 396 399 396 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 535 539 535 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 639 643 639 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 655 659 655 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 669 677 669 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g003">Figure 3</xref>
###xml 763 767 763 767 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 783 787 783 787 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 787 791 787 791 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP</sup>
###xml 805 813 805 813 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g003">Figure 3</xref>
###xml 140 145 <span type="species:ncbi:10090">mouse</span>
###xml 340 355 <span type="species:ncbi:10090">transgenic mice</span>
###xml 386 390 <span type="species:ncbi:10090">mice</span>
###xml 737 741 <span type="species:ncbi:10090">mice</span>
We next determined whether complete Pten inactivation in the prostate would further affect CaP tumor progression. To this end, we generated mouse mutants in which Pten exons 4 and 5 are flanked by loxP sites (Figure 3A; see Materials and Methods). The Neo cassette was excised from the locus in vivo by intercrossing Ptenhy/+ with EIIA-Cre transgenic mice (Lakso et al. 1996). In these mice, the Cre recombinase is expressed transiently, early in embryogenesis, allowing the production of a mosaic progeny that harbors in the germline Pten alleles in three different configurations: targeted unmodified (still retaining the Neo cassette), Pten floxed, or Pten deleted (Figure 3A). Breeding of these mosaic mutants allowed us to generate mice heterozygous for the Pten floxed allele (PtenloxP mutants; see Figure 3B).
###end p 21
###begin p 22
###xml 13 17 13 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 17 21 17 21 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP</sup>
###xml 148 152 148 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 217 220 217 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 239 245 239 245 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PB-Cre</italic>
###xml 250 257 250 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PB-Cre4</italic>
###xml 272 275 272 275 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 338 346 338 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Probasin</italic>
###xml 348 350 348 350 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PB</italic>
###xml 367 387 367 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Maddison1">Maddison et al. 2000</xref>
###xml 389 403 389 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Wu1">Wu et al. 2001</xref>
###xml 410 412 410 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PB</italic>
###xml 510 529 510 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Matusik1">Matusik et al. 1986</xref>
###xml 550 556 550 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PB-Cre</italic>
###xml 591 595 591 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 759 763 759 763 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 892 899 892 899 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PB-Cre4</italic>
###xml 906 920 906 920 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Wu1">Wu et al. 2001</xref>
###xml 927 930 927 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 974 978 974 978 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2 PB</sub>
###xml 971 978 971 978 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ARR<sub>2 PB</sub></italic>
###xml 1013 1015 1013 1015 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PB</italic>
###xml 1040 1046 1040 1046 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PB-Cre</italic>
###xml 1053 1073 1053 1073 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Maddison1">Maddison et al. 2000</xref>
###xml 1101 1108 1101 1108 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PB-Cre4</italic>
###xml 1122 1125 1122 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 1171 1177 1171 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PB-Cre</italic>
###xml 1191 1194 1191 1194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 1305 1309 1305 1309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1368 1376 1368 1376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g004">Figure 4</xref>
###xml 1394 1400 1394 1400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PB-Cre</italic>
###xml 1405 1412 1405 1412 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PB-Cre4</italic>
###xml 1436 1440 1436 1440 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1440 1444 1440 1444 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP</sup>
###xml 1474 1485 1474 1485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PB-Cre/Pten</italic>
###xml 1485 1494 1485 1494 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 1521 1525 1521 1525 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1525 1528 1525 1528 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 1541 1553 1541 1553 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PB-Cre4/Pten</italic>
###xml 1553 1562 1553 1562 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 1589 1593 1589 1593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1593 1596 1593 1596 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 1611 1619 1611 1619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g003">Figure 3</xref>
###xml 22 26 <span type="species:ncbi:10090">mice</span>
###xml 334 337 <span type="species:ncbi:10116">rat</span>
###xml 1009 1012 <span type="species:ncbi:10116">rat</span>
###xml 1109 1113 <span type="species:ncbi:10090">mice</span>
###xml 1178 1182 <span type="species:ncbi:10090">mice</span>
###xml 1413 1417 <span type="species:ncbi:10090">mice</span>
As expected, PtenloxP mice were born following Mendelian frequencies, viable and fertile, and were utilized for the conditional inactivation of the Pten gene in the prostate. To this end, we made use of two different Cre transgenic lines, PB-Cre and PB-Cre4, in which the Cre gene is under the control of two distinct versions of the rat Probasin (PB) gene promoter (Maddison et al. 2000; Wu et al. 2001). The PB gene is expressed in the prostatic epithelium postpuberty since the gene is androgen responsive (Matusik et al. 1986). Hence, using both PB-Cre transgenic lines, excision of the Pten gene would occur in the prostatic epithelium postpuberty. This is of relevance because it avoids any possible developmental effect due to complete inactivation of Pten during prostate organogenesis. The main difference in the two lines essentially resides in the strength of the promoter. In the PB-Cre4 line (Wu et al. 2001), the Cre gene is driven by a composite promoter, ARR2 PB, which is a derivative of the rat PB promoter from which the PB-Cre line (Maddison et al. 2000) was originally generated. PB-Cre4 mice express Cre at high levels and at high penetrance, while PB-Cre mice express Cre at lower levels and in fewer cells. This could in turn result in a more focal or more diffuse inactivation on Pten in the prostatic epithelium, as we could indeed document (Figure 4A). Also of note, PB-Cre and PB-Cre4 mice were crossed with PtenloxP mutants in order to generate PB-Cre/PtenloxP/loxP (hereafter referred to as Ptenpc1 mutants) or PB-Cre4/PtenloxP/loxP (hereafter referred to as Ptenpc2 mutants) (see Figure 3C).
###end p 22
###begin title 23
The Dose of Pten Dictates Tumor Progression in the Prostate
###end title 23
###begin p 24
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 86 90 86 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 90 93 90 93 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 98 102 98 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 102 105 102 105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 173 177 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 275 283 275 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g005">Figure 5</xref>
###xml 289 290 289 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g005">5</xref>
###xml 343 347 343 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 347 352 347 352 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1/2</sup>
###xml 378 382 378 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 382 386 382 386 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 434 438 434 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 438 441 438 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 447 451 447 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 451 454 451 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 625 629 625 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 629 632 629 632 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 669 677 669 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g004">Figure 4</xref>
###xml 680 688 680 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g005">Figure 5</xref>
###xml 695 699 695 699 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 699 702 699 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 813 821 813 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g004">Figure 4</xref>
###xml 824 832 824 832 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g005">Figure 5</xref>
###xml 870 874 870 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 933 937 933 937 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 937 940 937 940 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 948 952 948 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 952 955 952 955 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 969 977 969 977 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g004">Figure 4</xref>
###xml 980 984 980 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 984 987 984 987 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 1001 1005 1001 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1005 1008 1005 1008 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 1178 1186 1178 1186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g004">Figure 4</xref>
###xml 1230 1234 1230 1234 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1234 1237 1234 1237 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 1305 1309 1305 1309 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1309 1312 1309 1312 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 1326 1334 1326 1334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g004">Figure 4</xref>
###xml 1337 1345 1337 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g005">Figure 5</xref>
###xml 1349 1353 1349 1353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1353 1356 1353 1356 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 1474 1478 1474 1478 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1478 1481 1478 1481 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 1663 1671 1663 1671 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g004">Figure 4</xref>
###xml 115 119 <span type="species:ncbi:10090">Mice</span>
###xml 1357 1361 <span type="species:ncbi:10090">mice</span>
###xml 1482 1486 <span type="species:ncbi:10090">mice</span>
We next studied the impact of complete Pten inactivation on prostate tumorigenesis in Ptenpc1 and Ptenpc2 mutants. Mice were followed over time exactly as described for the Pten hypomorphic series by serial MRI and pathological analysis over a period of approximately 18 mo (Figure 5D and 5E). Strikingly, we observed a dramatic difference in Ptenpc1/2 mutants when compared to Ptenhy/- mutants, but also, importantly, when comparing Ptenpc1 with Ptenpc2 mutants. MRI and macroscopic postmortem analysis of the prostate revealed a rapid massive enlargement of all the prostatic lobes already manifested from 2-3 mo of age in Ptenpc2 mutants at complete penetrance (see Figure 4B; Figure 5D). In Ptenpc1 mutants, the enlargement was less pronounced at early stages and undetectable by MRI, but still apparent (see Figure 4B; Figure 5D). As aforementioned, the pattern of Pten inactivation in the prostatic epithelium was different in Ptenpc1 versus Ptenpc2 mutants (see Figure 4A; Ptenpc1 focal versus Ptenpc2 widespread). This difference also correlated with a clear difference in both the morphology and proliferative rates of the prostatic epithelium in these two models (see Figure 4A; see also the following paragraph). Thus, Ptenpc2 mutants displayed a much more severe prostate enlargement than did Ptenpc1 mutants (see Figure 4B; Figure 5D). Ptenpc1 mice displayed focal areas of epithelial hyperplasia, with enlarged glands formed by relatively regular cells, while Ptenpc2 mice presented disorganized hyperplastic glands in all lobes with signs of cellular dysplasia, containing large, irregular cells, forming at times cryptic glandular formations (see Figure 4A).
###end p 24
###begin p 25
###xml 71 75 71 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 75 78 75 78 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 87 90 87 90 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 220 228 220 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g004">Figure 4</xref>
###xml 231 239 231 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g005">Figure 5</xref>
###xml 277 281 277 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 593 601 593 601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g004">Figure 4</xref>
###xml 655 659 655 659 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 659 662 659 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 667 671 667 671 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 671 674 671 674 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 855 859 855 859 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 859 862 859 862 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 1027 1030 1027 1030 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 1023 1030 1023 1030 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>pc1</sup></italic>
###xml 1141 1149 1141 1149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g004">Figure 4</xref>
###xml 1180 1184 1180 1184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1184 1187 1184 1187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 1255 1259 1255 1259 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1259 1262 1259 1262 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 1339 1343 1339 1343 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 1335 1343 1335 1343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>hy/&#8722;</sup></italic>
###xml 91 95 <span type="species:ncbi:10090">mice</span>
###xml 1263 1267 <span type="species:ncbi:10090">mice</span>
Even more strikingly, however, pathological analysis of prostates from Ptenpc1 and Ptenpc2 mice revealed in both mutants, at complete penetrance, the development of invasive and diffuse CaP after a variable latency (see Figure 4B; Figure 5E). Tumors were in both cases made of Pten null cells (data not shown). Continuity of local invasive disease with that of intraepithelial lumens was often observed. The tumors were composed of rather large, mature epithelial cells. Neuroendocrine features, such as cytoplasmic granularity and small round cells, were not seen in the tumors analyzed (see Figure 4B). Although the tumors were clearly invasive in both Ptenpc1 and Ptenpc2 mutants with disruption of the basement membrane and clear signs of organ infiltration, once again we observed differences in the CaPs from these two models. In many instances, in Ptenpc2 mutants more than one prostate lobe was completely effaced by the infiltrating neoplastic cells, suggesting a multifocal tumor origin, while invasive tumors in Ptenpc1 mutants were often affecting only one lobe at a time and the extent of the infiltration was less diffuse (see Figure 4B). In addition, tumors in the Ptenpc1 animals were well-to-moderately differentiated while tumors in the Ptenpc2 mice were in general high-grade, undifferentiated lesions. In contrast, Ptenhy/- mutants displayed a spectrum of phenotypes, from well to undifferentiated and occasionally to locally invasive phenotypes, as previously shown.
###end p 25
###begin p 26
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
Thus, Pten conditional inactivation in the prostate leads to invasive and diffuse CaP at complete penetrance.
###end p 26
###begin title 27
Effects of the Pten Dose on the Biology of the Prostatic Epithelium
###end title 27
###begin p 28
###xml 180 184 180 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 184 187 184 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 189 193 189 193 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 193 196 193 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 198 202 198 202 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 202 206 202 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 212 216 212 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 216 219 216 219 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 267 271 267 271 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 271 274 271 274 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 322 326 322 326 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 275 279 <span type="species:ncbi:10090">mice</span>
We studied the molecular and biological consequences of Pten dose variations in the prostatic epithelium of our various mutants. We included in the analysis age-matched (8-wk-old) Pten+/+, Pten+/-, Ptenhy/-, and Ptenpc2 males. The latter mutants were used instead of Ptenpc1 mice in view of the more widespread pattern of Pten inactivation observed in their prostates.
###end p 28
###begin p 29
###xml 256 260 256 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 280 288 280 288 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g005">Figure 5</xref>
###xml 396 400 396 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 400 403 400 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 431 435 431 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 435 438 435 438 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 451 455 451 455 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 812 820 812 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g001">Figure 1</xref>
###xml 892 896 892 896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 948 952 948 952 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 439 443 <span type="species:ncbi:10090">mice</span>
First, we determined whether reduction in the Pten dose would affect proliferation of epithelial cells. Upon Ki-67 staining, we observed a progressive increase in the proliferative rates of prostate epithelial cells, which correlated with the reduction in Pten expression levels (Figure 5A). For instance, approximately 10-fold more cells were found in active proliferation in the prostates from Ptenpc2 mutants when compared with Pten+/+ mice. Thus, Pten inactivation, in a dose-dependent manner, lends to epithelial cells a dramatic growth advantage in the prostate. By contrast, MEFs of all genotypes from the hypomorphic series did not show noticeable differences in their growth rates under standard culture conditions, while showing progressive activation of the Akt signaling pathway (data not shown; see Figure 1C). This may reflect an intrinsic differential cell-type sensitivity to Pten inactivation, also in agreement with the fact that Pten hypomorphism does not result in overall increased body size and weight.
###end p 29
###begin p 30
###xml 145 149 145 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 229 254 229 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">see Materials and Methods</xref>
###xml 371 395 371 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Vivanco1">Vivanco and Sawyers 2002</xref>
###xml 481 485 481 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 656 657 656 657 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g002">2</xref>
###xml 660 661 660 661 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g005">5</xref>
###xml 668 669 668 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g005">5</xref>
###xml 788 792 788 792 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 792 795 792 795 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 926 934 926 934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g005">Figure 5</xref>
###xml 986 990 986 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1074 1078 1074 1078 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1078 1081 1078 1081 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 1086 1090 1086 1090 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1090 1093 1090 1093 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
We next assessed whether and how the progressive reduction of the Pten dose would affect the functions of key downstream targets such as Akt, p27Kip1, mTOR, and FOXO3 by immunohistochemistry (IHC) and Western blot (WB) analysis (see Materials and Methods). As aforementioned, we studied the status of Akt phosphorylation, the major known biochemical effect of Pten loss (Vivanco and Sawyers 2002), using an anti-phospho-Akt-specific antibody on cells and extracts from the various Pten mutants. Staining of prostates from various genotypes with this antibody increased proportionally to the decrease in Pten levels as confirmed by WB analysis (see Figures 2B, 5B, and 5C; data not shown). In addition, IHC analysis revealed a drastically different staining pattern in prostate cells from Ptenpc2 mutants when compared with cells from other genotypes in that phospho-Akt was found to overtly accumulate at the plasma membrane (Figure 5C). A similar staining pattern was observed both in Pten null epithelium prior to tumor occurrence and in cells from overt tumors from both Ptenpc1 and Ptenpc2 mutants (data not shown). Thus, Akt is progressively activated by a reduction in the Pten dose, which in turn results in its recruitment to the plasma membrane.
###end p 30
###begin p 31
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 55 59 55 59 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 138 142 138 142 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 274 292 274 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Brunet1">Brunet et al. 1999</xref>
###xml 365 369 365 369 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 371 395 371 395 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Mamillapalli1">Mamillapalli et al. 2001</xref>
###xml 397 414 397 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Liang1">Liang et al. 2002</xref>
###xml 416 432 416 432 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Shin1">Shin et al. 2002</xref>
###xml 434 455 434 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Viglietto1">Viglietto et al. 2002</xref>
###xml 580 599 580 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Gingras1">Gingras et al. 2001</xref>
###xml 678 682 678 682 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 704 708 704 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 708 711 708 711 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 716 720 716 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 720 723 720 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 727 731 727 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 724 731 724 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p27<sup>Kip1</sup></italic>
###xml 731 734 731 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 753 779 753 779 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Di4">Di Cristofano et al. 2001a</xref>
###xml 830 834 830 834 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 860 864 860 864 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 864 868 864 868 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 873 877 873 877 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 877 880 877 880 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 890 898 890 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g005">Figure 5</xref>
###xml 921 925 921 925 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 1019 1027 1019 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g005">Figure 5</xref>
###xml 1082 1086 1082 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1203 1228 1203 1228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="sec" rid="s4">see Materials and Methods</xref>
###xml 1280 1284 1280 1284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1284 1287 1284 1287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 1292 1296 1292 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1296 1300 1296 1300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 1441 1445 1441 1445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1445 1448 1445 1448 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 1490 1498 1490 1498 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g005">Figure 5</xref>
###xml 1511 1515 1511 1515 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1613 1617 1613 1617 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1617 1620 1617 1620 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 1630 1638 1630 1638 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g005">Figure 5</xref>
###xml 1484 1488 <span type="species:ncbi:10090">mice</span>
We next studied the effects of Pten inactivation on p27Kip1, FOXO3, and mTOR, known targets of Akt kinase activity. Phosphorylation of p27Kip1 and FOXO3 by Akt results in their functional inactivation through multiple mechanisms such as nuclear export, in the case of FOXO (Brunet et al. 1999), or inhibition of nuclear import and downregulation, in the case of p27Kip1 (Mamillapalli et al. 2001; Liang et al. 2002; Shin et al. 2002; Viglietto et al. 2002). By contrast, Akt activation results in mTOR phosphorylation and increased protein translation and translation initiation (Gingras et al. 2001). We previously reported that the localization or the expression levels of p27Kip1 were not affected in Pten+/- and Pten+/-/p27Kip1-/- compound mutants (Di Cristofano et al. 2001a). By contrast, a progressive downregulation in p27Kip1 staining was observed in Ptenhy/- and Ptenpc2 mutants (Figure 5C; data not shown). p27Kip1 was apparently expressed at lower levels, and fewer cells were found to express the protein (Figure 5C). We also studied the status of FOXO3 in the various Pten mutants, analyzing both its localization and threonine phosphorylation with a specific anti-phospho-FOXO3 antibody (see Materials and Methods). While no noticeable differences were observed in Pten+/- and Ptenhy/- mutants (data not shown), increase in the levels of anti-phospho-FOXO3 cytoplasmic staining were observed in prostate epithelial cells from Ptenpc2 mutants when compared to wild-type mice (Figure 5C). Complete Pten inactivation also resulted in an increase in mTOR phosphorylation in the prostatic epithelium of Ptenpc2 mutants (Figure 5C).
###end p 31
###begin p 32
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 89 93 89 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 93 98 93 98 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1/2</sup>
###xml 284 292 284 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g005">Figure 5</xref>
###xml 298 299 298 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g005">5</xref>
Thus, the progressive reduction of the Pten dose (and the extent of Pten inactivation in Ptenpc1/2 mutants) affects the proliferative rate of the prostatic epithelium and results in molecular changes, which in turn dictates the natural history of these lesions and tumor progression (Figure 5D and 5E).
###end p 32
###begin title 33
Discussion
###end title 33
###begin p 34
###xml 542 550 542 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g006">Figure 6</xref>
Our analysis allows a detailed deconstruction the molecular genetics underlying cancer progression in the prostate and the assessment of the key relevance of Pten and subtle variations in its dose in controlling this process. Based on our findings, we can now attribute distinct preneoplastic or malignant pathological entities to distinct molecular states. Furthermore, this new knowledge allows the reclassification, on the basis of their true molecular nature, of pathological lesions that at a superficial analysis appeared very similar (Figure 6).
###end p 34
###begin p 35
In this supposedly linear and multistep process, which separates two extremely different anatomical and pathological entities, a normal prostatic epithelium from an invasive CaP, there are, in between, a discrete number of anatomically distinct intermediary steps, such as prostate hyperplasia > displasia/low-grade PIN > high-grade PIN > locally invasive CaP > diffused CaP. These entities have been recognized before on the basis of their pathological features. The fact that we are now able to correlate these anatomical stages with specific molecular events, such as the level of expression of a single tumor suppressor gene, not only represents an integration of anatomical, descriptive findings with biological data, but also offers the opportunity of therapeutic interventions.
###end p 35
###begin p 36
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 148 152 148 152 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 545 553 545 553 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g006">Figure 6</xref>
###xml 555 579 555 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Cordon-Cardo1">Cordon-Cardo et al. 1998</xref>
###xml 581 607 581 607 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Di4">Di Cristofano et al. 2001a</xref>
###xml 658 662 658 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 853 861 853 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g006">Figure 6</xref>
###xml 863 889 863 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Di4">Di Cristofano et al. 2001a</xref>
###xml 66 71 <span type="species:ncbi:10090">mouse</span>
###xml 160 165 <span type="species:ncbi:10090">mouse</span>
###xml 190 195 <span type="species:ncbi:9606">human</span>
###xml 846 851 <span type="species:ncbi:10090">mouse</span>
We show in this study that inactivation of one Pten allele in the mouse may lead to prostate epithelial hyperplasia, as complete inactivation of p27Kip1 in the mouse leads to what resembles human benign prostate hyperplasia (BPH). However, these two lesions are very different in nature and outcome: the first, in fact, impacts only on epithelial elements and over time evolves to low-grade PIN, while the second impacts on both epithelial and stroma elements, representing hyperplasia of the whole organ, but does not evolve toward malignancy (Figure 6; Cordon-Cardo et al. 1998; Di Cristofano et al. 2001a). This obviously does not exclude that loss of p27Kip1 expression when accompanied by additional genetic events (e.g., loss of PTEN) may lead to a completely different outcome, as is also supported by our previous in vivo analysis in the mouse (Figure 6; Di Cristofano et al. 2001a).
###end p 36
###begin p 37
###xml 93 97 93 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 97 101 97 101 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 226 234 226 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g006">Figure 6</xref>
###xml 378 382 378 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 422 426 422 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 610 614 610 614 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 672 676 672 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 745 753 745 753 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g006">Figure 6</xref>
###xml 317 325 <span type="species:ncbi:9606">patients</span>
Moreover, our data demonstrate that a further reduction in the Pten dose, as observed in the Ptenhy/- mutants, accelerates tumor progression dramatically, eventually resulting in high-grade PIN and locally invasive carcinoma (Figure 6). This fact has very important therapeutic implications. As a large number of CaP patients (more than 80%) display at presentation loss of one PTEN allele, but do retain the other normal PTEN allele, it could be proposed that high-grade PIN or locally invasive prostate carcinomas could be prevented or treated by pharmacologically modulating the expression of the remaining PTEN allele or by antagonizing the downstream consequences of PTEN downregulation or partial inactivation (e.g., PI3K/mTOR activation; Figure 6).
###end p 37
###begin p 38
###xml 65 69 65 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 69 73 69 73 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 135 139 135 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 156 164 156 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g002">Figure 2</xref>
###xml 370 374 370 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 374 377 374 377 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 391 395 391 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 395 399 395 399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 470 478 470 478 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g006">Figure 6</xref>
###xml 940 944 940 944 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 378 382 <span type="species:ncbi:10090">mice</span>
While the massive prostate hyperplasia/dysplasia observed in the Ptenhy/- mutants is not, as expected, accompanied by complete loss of Pten expression (see Figure 2E), the low penetrance of the invasive CaP in these mutants strongly suggest that additional events have to occur for this pathological transition to occur. Nevertheless, it is important to underscore that Pten+/- mice, unlike Ptenhy/- mutants, do not develop invasive CaP, but only low-grade PIN lesions (Figure 6). Thus, a further reduction of the Pten dose seems to be essential for this process. Several possibilities, not mutually exclusive, could be entertained: (i) a more severe reduction in the Pten dose could facilitate cooperative tumorigenesis by rendering the cells permissive and sensitive to the activation of additional oncogenic pathways; (ii) the massive prostate hyperplasia could facilitate the accumulation of additional genetic hits (including complete Pten loss) by simply expanding the pool of actively dividing cells; (iii) a more severe reduction in the Pten dose could protect cells from apoptotic programs that are normally triggered by the occurrence of damaging genetics events.
###end p 38
###begin p 39
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 18 22 18 22 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 339 343 339 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 343 347 343 347 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 512 516 512 516 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 509 516 509 516 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p27<sup>Kip1</sup></italic>
###xml 516 519 516 519 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 649 665 649 665 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Fero1">Fero et al. 1996</xref>
###xml 667 687 667 687 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Kiyokawa1">Kiyokawa et al. 1996</xref>
###xml 689 709 689 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Nakayama1">Nakayama et al. 1996</xref>
###xml 715 719 715 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 719 723 719 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 837 845 837 845 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g006">Figure 6</xref>
###xml 935 945 935 945 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Drosophila</italic>
###xml 990 994 990 994 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1101 1122 1101 1122 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Oldham1">Oldham and Hafen 2003</xref>
###xml 520 524 <span type="species:ncbi:10090">mice</span>
###xml 935 945 <span type="species:ncbi:7227">Drosophila</span>
The fact that Ptenhy/- mutants develop massive prostate hyperplasia not accompanied by an overall increase in body weight and size underscores the fact that different tissues and organs are differentially sensitive to Pten dose variations, the prostatic epithelium being one of the most sensitive. In agreement with this notion, MEFs from Ptenhy/- mutants do not display proliferative advantage in standard culture condition over wild-type MEFs. In this respect, it is also important to remember that, unlike p27Kip1-/- mice, which display hyperplasia of both stromal and parenchymal components in the prostate (as well as an increase in body mass; Fero et al. 1996; Kiyokawa et al. 1996; Nakayama et al. 1996), in Ptenhy/- mutants it is specifically the prostatic epithelium that actively proliferates, leading to prostate hyperplasia (Figure 6). Interestingly, this does not parallel what is observed in other model systems, such as Drosophila, where dose variations in the expression of Pten or downstream signaling components (e.g., TOR) do result in variations in body size and mass (reviewed in Oldham and Hafen 2003).
###end p 39
###begin p 40
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 168 172 168 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 176 182 176 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Nkx3.1</italic>
###xml 226 252 226 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Di4">Di Cristofano et al. 2001a</xref>
###xml 254 276 254 276 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Kwabi-Addo1">Kwabi-Addo et al. 2001</xref>
###xml 278 293 278 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Kim1">Kim et al. 2002</xref>
###xml 295 317 295 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Abate-Shen1">Abate-Shen et al. 2003</xref>
###xml 381 385 381 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 512 520 512 520 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g006">Figure 6</xref>
###xml 577 581 577 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 776 780 776 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 909 913 909 913 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 1013 1017 1013 1017 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 1079 1087 1079 1087 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g006">Figure 6</xref>
###xml 1208 1212 1208 1212 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 1422 1426 1422 1426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1715 1719 1715 1719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1240 1245 <span type="species:ncbi:9606">human</span>
###xml 1447 1452 <span type="species:ncbi:10090">mouse</span>
While we and others had previously implicated Pten heterozygous loss in prostate tumorigenesis when in cooperation with additional oncogenic events (such as loss of p27Kip1 or Nkx3.1 or the expression of the large T oncogene; Di Cristofano et al. 2001a; Kwabi-Addo et al. 2001; Kim et al. 2002; Abate-Shen et al. 2003), we demonstrate in this article that complete inactivation of Pten alone in the prostate has already catastrophic consequences leading to invasive, diffuse, and highly aggressive malignancies (Figure 6). Although it cannot be formally excluded that complete Pten loss would still cooperate with additional oncogenic events toward full-blown transformation, this finding underscores once more the exquisite sensitivity of the prostatic epithelium to loss of Pten. This information should be factored in when tailoring the treatment of CaP or high-grade PIN lesions that have completely lost PTEN function. These lesions may be extremely sensitive to PI3K or mTOR inhibitors, while modulation of PTEN expression would not be a therapeutic option in these cases (Figure 6). On the basis of these findings, it would seem therefore of paramount importance to routinely assess the status of the PTEN gene and its expression in human CaPs and precancerous lesions as a key biomarker to opt for the most appropriate therapeutic or chemopreventive intervention modalities. It remains to be seen whether complete Pten inactivation in the mouse prostate also influences the metastatic potential of these invasive CaPs alone or in combination with additional oncogenic events. In this respect, while MRI and postmortem analyses have indeed revealed the presence of lung neoplastic lesions in our conditional Pten mutants, morphological and molecular analyses have so far excluded the metastatic nature of these tumors (M. Niki et al., unpublished data).
###end p 40
###begin p 41
###xml 57 83 57 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">progressively quantitative</italic>
###xml 239 243 239 243 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 399 407 399 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g005">Figure 5</xref>
###xml 561 565 561 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 682 686 682 686 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 837 854 837 854 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Liang1">Liang et al. 2002</xref>
###xml 856 872 856 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Shin1">Shin et al. 2002</xref>
###xml 874 895 874 895 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Viglietto1">Viglietto et al. 2002</xref>
###xml 970 981 970 981 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">progressive</italic>
###xml 780 785 <span type="species:ncbi:9606">human</span>
The stepwise reduction in the Pten dose results in clear progressively quantitative changes in the prostate epithelial cells prior to tumor development. Increased cellular proliferation correlates with increased phosphorylation of Akt. In Pten null epithelial cells, both in the preneoplastic stage or in overt CaPs, phospho-Akt is found to accumulate almost exclusively at the plasma membrane (see Figure 5C). Whether this represents the extreme consequence of Akt superactivation or rather reflects a genuine qualitative change in Akt biology and function in Pten null prostate epithelial cells remains to be determined. It also remains to be resolved whether the reduction in p27Kip1 expression is also associated with its cytoplasmic relocalization, as previously reported in human breast cancer cells suffering AKT hyperactivation (Liang et al. 2002; Shin et al. 2002; Viglietto et al. 2002). Taken together, this analysis supports a Pten dose-dependent model with progressive changes at the molecular level, arguing against a Pten threshold model for tumor suppression.
###end p 41
###begin p 42
###xml 19 30 19 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">qualitative</italic>
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 144 148 144 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 148 151 148 151 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 223 227 223 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 227 231 227 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 296 300 296 300 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 300 303 300 303 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 345 349 345 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 349 353 349 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 363 371 363 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g006">Figure 6</xref>
###xml 152 156 <span type="species:ncbi:10090">mice</span>
###xml 304 308 <span type="species:ncbi:10090">mice</span>
###xml 354 358 <span type="species:ncbi:10090">mice</span>
By contrast, clear qualitative morphological changes were observed in the prostate epithelium when analyzing the Pten hypomorphic series. While Pten+/- mice never display massive prostatic enlargement, further reduction to Ptenhy/- levels leads to a sharp increase in prostate mass. In addition, Pten+/- mice never develop invasive CaP, whereas Ptenhy/- mice do (Figure 6). These data clearly support a threshold model for Pten tumor suppression at the physiopathological level.
###end p 42
###begin p 43
###xml 103 107 103 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 149 153 149 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 153 156 153 156 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 168 171 168 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 181 185 181 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 185 188 185 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 317 321 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 321 324 321 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 422 426 422 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 426 429 426 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 447 451 447 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 451 454 451 454 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 525 529 525 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 634 637 634 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 637 637 637 637 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 733 737 733 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 787 791 787 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
###xml 430 434 <span type="species:ncbi:10090">mice</span>
Similarly, qualitative morphological changes are also caused by the number of cells suffering complete Pten inactivation, as observed when comparing Ptenpc1 versus Ptenpc2 mice. In Ptenpc2 mice, signs of cellular dysplasia and irregular glandular formations were frequently observed, but they were mostly absent from Ptenpc1 mutants. Along the same tenet, profound mass increase was always observed at early timepoints in Ptenpc2 mice, but not in Ptenpc1 mutants. This is likely due to the marked difference in the number of Pten null cells present in the parenchyma of these two models at puberty, reflecting the different levels of Creexpression in the two models. These observations are also consistent with a threshold model for Pten tumor suppression as a function of the number of Pten null cells in a given organ.
###end p 43
###begin p 44
###xml 157 162 <span type="species:ncbi:9606">human</span>
###xml 213 218 <span type="species:ncbi:9606">human</span>
###xml 322 327 <span type="species:ncbi:10090">mouse</span>
###xml 399 404 <span type="species:ncbi:9606">human</span>
###xml 722 727 <span type="species:ncbi:9606">human</span>
###xml 745 750 <span type="species:ncbi:10090">mouse</span>
From a biological standpoint, it will be challenging to determine in the future whether this "field effect" would also play a role in the natural history of human CaP. On the one hand, it could be speculated that human CaP likely arises from a single transformed cell and that therefore that the field effects observed in mouse models will not be critical determinants in the natural history of the human disease. On the other hand, the multistep nature of the neoplastic process (and hence the genetic heterogeneity of the lesion) and the fact that the tumor will eventually grow to form "fields" of neoplastic cells may suggest that these effects, as well as stromal and parenchymal interactions, are key aspects of the human disease that the mouse model can recapitulate.
###end p 44
###begin p 45
###xml 166 170 166 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
Taken together, our findings demonstrate the key importance of Pten in CaP tumor suppression and the dramatic impact that subtle changes in Pten levels and extent of Pten inactivation may have on tumor initiation and progression in the prostate.
###end p 45
###begin title 46
Materials and Methods
###end title 46
###begin title 47

###end title 47
###begin title 48
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 48
###begin p 49
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 39 42 39 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 80 105 80 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Di2">Di Cristofano et al. 1998</xref>
###xml 107 112 107 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Di4">2001a</xref>
###xml 236 244 236 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g001">Figure 1</xref>
###xml 249 257 249 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g003">Figure 3</xref>
###xml 308 312 308 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 312 313 312 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 312 313 312 313 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>&#8722;</sup></bold>
###xml 318 322 318 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 322 324 322 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy</sup>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
###xml 115 119 <span type="species:ncbi:10090">Mice</span>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
Generation and characterization of Pten+/- mice have been described perviously (Di Cristofano et al. 1998, 2001a). Mice were genotyped by PCR on tail DNA or by Southern blotting as shown. Hypomorphic mice were generated as described in Figure 1 and Figure 3 and tail DNA genotyped by PCR for presence of the Pten- and Ptenhy alleles (using primers 1 and 2 described below) or by Southern blotting.
###end p 49
###begin title 50
###xml 53 57 53 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Targeting vector and generation of prostate-specific Pten-deficient mice
###end title 50
###begin p 51
###xml 107 111 107 111 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 186 189 186 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kpn</italic>
###xml 191 194 191 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 220 224 220 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 250 253 250 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 357 360 357 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Not</italic>
###xml 985 989 983 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 989 999 987 997 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP-neo/+</sup>
###xml 1021 1029 1019 1027 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EIIA-Cre</italic>
###xml 1047 1064 1045 1062 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Lakso1">Lakso et al. 1996</xref>
###xml 1199 1203 1197 1201 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1224 1228 1222 1226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1246 1250 1244 1248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1250 1258 1248 1256 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP-neo</sup>
###xml 1282 1286 1280 1284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1286 1290 1284 1288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxp</sup>
###xml 1871 1875 1850 1854 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1875 1884 1854 1863 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 1911 1917 1890 1896 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PB-Cre</italic>
###xml 1935 1955 1914 1934 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Maddison1">Maddison et al. 2000</xref>
###xml 1965 1972 1944 1951 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PB-Cre4</italic>
###xml 1990 2004 1969 1983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Wu1">Wu et al. 2001</xref>
###xml 2040 2044 2019 2023 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 9 14 <span type="species:ncbi:10090">mouse</span>
###xml 101 106 <span type="species:ncbi:10090">mouse</span>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
###xml 1000 1004 <span type="species:ncbi:10090">mice</span>
###xml 1030 1045 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1182 1186 <span type="species:ncbi:10090">mice</span>
###xml 1373 1377 <span type="species:ncbi:10090">mice</span>
###xml 1885 1889 <span type="species:ncbi:10090">mice</span>
###xml 1918 1933 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1973 1988 <span type="species:ncbi:10090">transgenic mice</span>
A 129/Sv mouse genomic library (Stratagene, La Jolla, California, United States) was screened with a mouse Pten probe containing exons 4-6. To generate the targeting construct, a 4.1 Kb KpnI-BamHI fragment containing 5' Pten genomic DNA and a 2.0 Kb XbaI fragment containing 3' genomic DNA were cloned into pPNT. The targeting construct was linearized with NotI and electroporated into CJ7 ES cells. Transfectants were selected in G418 (350 mug/ml) and gancyclovir (2 muM) and expanded for Southern blot analysis using a 3' probe. Chimeric mice were produced by microinjection of two independently generated targeted ES cell clones with normal karyotypes into E3.5 C57BL6/J blastocysts, then transferred to pseudopregnant foster mothers. Chimeric males were mated with C57BL6/J females (Jackson Laboratory, Bar Harbor, Maine, United States), and germline transmission of the mutant allele was verified by Southern blot analysis of tail DNA from agouti coat-colored F1 offspring. Next, PtenloxP-neo/+ mice were mated with EIIA-Cre transgenic mice (Lakso et al. 1996), and tail DNA from offspring was subjected to Southern blot analysis using probe 6.1. Through these crosses, mosaic mice harboring a Pten wild-type allele, a Pten targeted allele (PtenloxP-neo), and a floxed allele (Ptenloxp) in their germline were generated. These mosaic mutants were mated with wild-type mice and tail DNA from offspring subjected to Southern blot analysis using probe 6.1 and to PCR analysis using primer 1 (5'-AAAAGTTCCCCTGCTGATGATTTGT-3') and primer 2 (5'-TGTTTTTGACCAATTAAAGTAGGCTGTG-3'). PCR conditions were 35 cycles (30 sec at 95degreesC, 1 min at 55degreesC, and 1 min at 72degreesC) using HotStarTaq Master Mix (Qiagen, Valencia, California, United States), primer (0.25 muM), and DNA (50 ng). To detect the deleted allele, primer 3 (5'-CCCCCAAGTCAATTGTTAGGTCTGT-3') was used. PtenloxP/loxP mice were next mated with PB-Cre transgenic mice (Maddison et al. 2000) or male PB-Cre4 transgenic mice (Wu et al. 2001) for conditional prostate-specific Pten inactivation.
###end p 51
###begin title 52
Autopsy and histopathology
###end title 52
###begin p 53
Animals were autopsied and all tissues were examined regardless of their pathological status. Normal and tumor tissue samples were fixed in 10% buffered formalin and embedded in paraffin. Sections (5 mum) were stained with hematoxylin and eosin (H&E) according to standard protocols.
###end p 53
###begin title 54
Cells
###end title 54
###begin p 55
###xml 106 110 106 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 110 114 110 114 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/+</sup>
###xml 119 123 119 123 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 123 126 123 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 244 270 244 270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Di5">Di Cristofano et al. 2001b</xref>
###xml 694 698 694 698 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1231 1235 1213 1217 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HPRT</italic>
###xml 1623 1649 1605 1631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Di5">Di Cristofano et al. 2001b</xref>
Primary MEFs derived from ten littermate embryos were produced as follows. MEFs were obtained by crossing Ptenhy/+ and Pten+/- animals, embryos were harvested at 13.5 dpc, and individual MEFs were produced and cultured as previously described (Di Cristofano et al. 2001b) and genotyped as described above. At passage 2, cells were harvested for WB analysis (see below) and mRNA extraction by the TRIZOL method (GIBCO-BRL, Carlsbad, California, United States) and cDNA produced using the SuperScript First-Strand Kit for RT-PCR (Invitrogen, Carlsbad, California, United States) according to the manufacturers' instructions. Semiquantitative PCR (yielding a 102 bp amplicon) was performed with a Pten exon 3-specific forward (5'-TGGATTCAAAGCATAAAAACCATTAC-3') and an exon 4- and exon 5-specific reverse primer (5'-CAAAAGGATACTGTGCAACTCTGC-3') using 30 cycles of 1 min at 95degreesC, 1 min at 55degreesC, and 1 min at 72degreesC) with the PCR optimizer kit (Invitrogen) and buffer A according to the manufacturer's protocols. PCR amplification of the cDNAs was performed for 25, 30, and 35 cycles, and the amplified products were found to be in the linear range at 30 cycles. PCR products from hypoxanthine phosphoribosyltransferase (HPRT) control amplification with 5'-CCTGCTGGATTACATTAAAGCACTG-3' and 5'-GTCAAGGGCATATCCAACAACAAAC-3' primers were used as standards (352 bp amplicon). For measuring proliferative rates of all MEF genotypes, cells were seeded in 12-well plates at 3,000 cells per well in medium containing 10% FBS and fixed at 2-d intervals. Analysis and quantification were performed as previously described (Di Cristofano et al. 2001b).
###end p 55
###begin title 56
WB analysis and densitometry
###end title 56
###begin p 57
###xml 289 290 289 290 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 292 293 292 293 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 588 588 588 588 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 704 705 704 705 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 719 720 719 720 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 838 864 838 864 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pbio.0000059-Di5">Di Cristofano et al. 2001b</xref>
###xml 650 654 <span type="species:ncbi:10090">mice</span>
###xml 1032 1038 <span type="species:ncbi:9986">rabbit</span>
###xml 1706 1711 <span type="species:ncbi:3750">Apple</span>
Prostates from dissected animals of all genotypes were briefly homogenized (using a Polytron homogenizer; Polytron Vertrieb, Bad Wildbad, Germany), and primary MEFs were harvested and directly lysed in 50 mM Tris (pH 7.5), 150 mM NaCl, 1 mM EDTA, 0.1% NP-40, 1 mM sodium ortho-vanadate (Na3VO4), 10 mM NaF, and protease inhibitor cocktail (Hoffmann-La Roche, Basel, Switzerland) and cleared by centrifugation; concentrations were determined by the Bio-Rad Protein Assay (Bio-Rad Laboratories, Hercules, California, United States); and samples were taken into an SDS sample loading buffer.Blood was taken from the retro-orbital cavity of anesthetized mice, red cells were lysed in lysis buffer (0.155 M NH4Cl, 10 mM KHCO3, 1 mM EDTA), and intact cells harvested by centrifugation. PBMCs were lysed in lysis buffer as previously described (Di Cristofano et al. 2001b), and protein concentrations were determined as above. Equivalents of 50 mug of lysate per lane were used for SDS-PAGE and WB analysis. Proteins were detected using a rabbit polyclonal anti-Pten antibody (anti-PTEN/MMAC-1 Ab-2; NeoMarkers, Lab Vision Corporation, Fremont, California, United States), anti-actin monoclonal antibody (mAb) AC-74 (Sigma, St. Louis, Missouri, United States) for normalization, and the Phospho-Akt Pathway Sampler Kit antibodies against Akt and phospho-Serine 473 of Akt (Cell Signaling Technology, Beverly, Massachusetts, United States) following the manufacturers' instructions. After visualization with the ECL system (Amersham Biosciences, Little Chalfont, United Kingdom), films were scanned and band density was quantified using MacBas v2.5 (Fuji Photo Film Company, Tokyo, Japan) on a Macintosh computer (Apple Computer, Sunnyvale, California, United States).
###end p 57
###begin title 58
IHC
###end title 58
###begin p 59
###xml 117 122 <span type="species:ncbi:10090">mouse</span>
###xml 366 372 <span type="species:ncbi:9986">Rabbit</span>
###xml 493 499 <span type="species:ncbi:9986">rabbit</span>
Tissues were fixed in 4% paraformaldehyde and embedded in paraffin, and 8 mum-thick sections were prepared. Anti-p27 mouse mAb (catalog #610242; BD Transduction Laboratories, San Diego, California, United States) was used at 0.5 mug/ml concentration. The IHC detection was performed with the MOM kit from Vector Laboratories (Burlingame, California, United States). Rabbit polyclonal phospho-Akt (Ser 473) antibody (catalog #9270 from Cell Signaling Technology) was used in 1:50 dilution, and rabbit polyclonal antibody PTEN/MMAC1 Ab-2 (catalog #RB-072-PO from NeoMarkers) was used at 1:200 dilution. The IHC detection was performed with the ABC kit from Vector Laboratories. These staining procedures were carried out by the automated staining processor Discovery from Ventana Medical Systems (Tucson, Arizona, United States).
###end p 59
###begin p 60
###xml 453 454 452 453 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 455 456 454 455 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Anti-Ki-67 antibody (Novocastra Laboratories Ltd., Newcastle-upon-Tyne, United Kingdom), anti-Cre antibody (Novagen, Madison, Wisconsin, United States), and polyclonal anti-phospho-mTOR antibody (Cell Signaling Technology) were purchased. Anti-phospho-FOXO3 (Thr 32) was a kind gift from Anne Brunet (Harvard University, Cambridge, Massachusetts, United States). Paraffin sections (5 mum thickness) were fixed in ice-cold acetone and incubated in 0.1% H2O2 for 15 min to inactivate internal peroxidase. Antigen retrieval was performed in 10 mM citric acid for 15 min using microwave. IHC staining was performed using biotinylated secondary antibodies followed by the Vectastain ABC Elite kit (Vector Laboratories).
###end p 60
###begin title 61
MRI analysis
###end title 61
###begin p 62
###xml 710 711 710 711 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 792 795 792 795 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">eff</sub>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
Mice were assessed individually by MRI for tumor establishment. Images were obtained on a 1.5T General Electric LX Echo Speed Signa scanner (General Electric Medical Systems, Milwaukee, Wisconsin, United States) using homemade foil solenoid coils (22 mm or 27 mm inner diameter). The mice were anesthetized with isofluorane. Images were acquired using a two-dimensional spin-echo pulse sequence. Initially, the animal was positioned in the coil in a holder, and sagittal scout (field of view, 120 mm) images obtained (TR = 300 ms, TE = 14 ms, one excitation per phase-encoding step, 256 x 128 matrix, 3.0 mm-thick slice, 1.5 mm slice separation) to localize the region of interest. Subsequently, high-quality T2-weighted fast spin-echo transverse images were obtained (TR = 3,000-5,000 ms, TEeff = 102 ms, echo train length = 12, 6-12 excitations per phase-encoding step, 1.5 mm thick slice, field of view = 40 mm, 0.5 mm slice separation, in plane resolution of 156 x156 mum or 156 x 208 mum).
###end p 62
###begin title 63
Statistical analysis
###end title 63
###begin p 64
Survival was calculated using the Kaplan-Meier method. Log rank tests were used to compare groups by using the SPSS 10 software package (SPSS Incorporated, Chicago, Illinois, United States).
###end p 64
###begin p 65
###xml 136 140 136 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 210 216 210 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PR-Cre</italic>
###xml 217 232 <span type="species:ncbi:10090">transgenic mice</span>
We thank Peter Scardino and Howard Scher for advice and discussions; Zhenbang Chen for help with genotyping and characterization of the Pten hypomorphic mutants; Lisette Anne Maddison for the genotyping of the PR-Cre transgenic mice; Katia Manova and Craig Farrell for assistance with the automated IHC procedures; Maria Socorro Jiao for assistance with pathological analysis; and Mihaela Lupu and Cornelia Matei for assistance with the MRI analysis. This study was supported, in part, by National Cancer Institute (NCI) grants (SPORE 92629 in Prostate Cancer, MMHCC CA-84292, and RO1 CA-82328) and by the I.T. Hirschl/M. Weill-Caulier Foundation to PPP and CC-C. Imaging analysis was supported by NCI grant R24CA83084 and an MSKCC NCI Core Grant to JAK.
###end p 65
###begin title 66
References
###end title 66
###begin article-title 67
###xml 8 12 8 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
Nkx3.1: Pten mutant mice develop invasive prostate adenocarcinoma and lymph node metastases
###end article-title 67
###begin article-title 68
PTEN function in mammalian cell size regulation
###end article-title 68
###begin article-title 69
Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor
###end article-title 69
###begin article-title 70
New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway
###end article-title 70
###begin article-title 71
###xml 32 36 32 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KIP1</sup>
###xml 32 36 32 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>KIP1</sup></italic>
Distinct altered patterns of p27KIP1 gene expression in benign prostatic hyperplasia and prostatic carcinoma
###end article-title 71
###begin article-title 72
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
The multiple roles of PTEN in tumor suppression
###end article-title 72
###begin article-title 73
Pten is essential for embryonic development and tumour suppression
###end article-title 73
###begin article-title 74
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Impaired Fas response and autoimmunity in Pten+/- mice
###end article-title 74
###begin article-title 75
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 12 16 12 16 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">KIP1</sup>
###xml 12 16 12 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>KIP1</sup></italic>
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse
###end article-title 75
###begin article-title 76
###xml 3 6 3 6 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">dok</sup>
###xml 120 127 120 127 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">bcr-abl</sup>
p62dok, a negative regulator of ras and mitogen-activated protein kinase (MAPK) activity, opposes leukemogenesis by p210bcr-abl
###end article-title 76
###begin article-title 77
###xml 107 111 107 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 122 126 <span type="species:ncbi:10090">mice</span>
A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27Kip1-deficient mice
###end article-title 77
###begin article-title 78
Regulation of translation initiation by FRAP/mTOR
###end article-title 78
###begin article-title 79
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
Mutation and expression analysis of the putative prostate tumour-suppressor gene PTEN
###end article-title 79
###begin article-title 80
###xml 98 105 98 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
An epi-allelic series of p53 hypomorphs created by stable RNAi produces distinct tumor phenotypes in vivo
###end article-title 80
###begin article-title 81
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis
###end article-title 81
###begin article-title 82
###xml 19 23 <span type="species:ncbi:10090">mice</span>
Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1)
###end article-title 82
###begin article-title 83
Mutation and cancer: Statistical study of retinoblastoma
###end article-title 83
###begin article-title 84
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression
###end article-title 84
###begin article-title 85
###xml 10 17 10 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
Efficient in vivo manipulation of mouse genomic sequences at the zygote stage
###end article-title 85
###begin article-title 86
PKB/Akt phosphorylates p27, impairs nuclear import of p27 and opposes p27-mediated G1 arrest
###end article-title 86
###begin article-title 87
###xml 51 66 <span type="species:ncbi:10090">transgenic mice</span>
Prostate specific expression of Cre recombinase in transgenic mice
###end article-title 87
###begin article-title 88
###xml 22 32 22 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN/MMAC1</italic>
The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate
###end article-title 88
###begin article-title 89
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
PTEN regulates the ubiquitin-dependent degradation of the CDK inhibitor p27(KIP1) through the ubiquitin E3 ligase SCF(SKP2)
###end article-title 89
###begin article-title 90
Regulation of prostatic genes: Role of androgens and zinc in gene expression
###end article-title 90
###begin article-title 91
###xml 34 37 34 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">cis</italic>
A "knockdown" mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1
###end article-title 91
###begin article-title 92
HLF/HIF-2alpha is a key factor in retinopathy of prematurity in association with erythropoietin
###end article-title 92
###begin article-title 93
###xml 16 20 16 20 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1</sup>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice lacking p27Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors
###end article-title 93
###begin article-title 94
Insulin/IGF and target of rapamycin signaling: A TOR de force in growth control
###end article-title 94
###begin article-title 95
###xml 62 66 <span type="species:ncbi:10090">mice</span>
Prostatic intraepithelial neoplasia in genetically engineered mice
###end article-title 95
###begin article-title 96
###xml 12 22 12 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten/Mmac1</italic>
###xml 26 30 <span type="species:ncbi:10090">mice</span>
Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems
###end article-title 96
###begin article-title 97
PKB/Akt mediates cell-cycle progression by phosphorylation of p27(Kip1) at threonine 157 and modulation of its cellular localization
###end article-title 97
###begin article-title 98
###xml 79 83 79 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN
###end article-title 98
###begin article-title 99
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 113 117 <span type="species:ncbi:10090">mice</span>
High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice
###end article-title 99
###begin article-title 100
Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer
###end article-title 100
###begin article-title 101
###xml 49 54 <span type="species:ncbi:9606">human</span>
The phosphatidylinositol 3-kinase AKT pathway in human cancer
###end article-title 101
###begin article-title 102
###xml 37 47 37 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten/MMAC1</italic>
###xml 60 65 <span type="species:ncbi:9606">human</span>
Inactivation of the tumor suppressor Pten/MMAC1 in advanced human prostate cancer through loss of expression
###end article-title 102
###begin article-title 103
###xml 50 53 50 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cre</italic>
###xml 65 70 <span type="species:ncbi:10090">mouse</span>
Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation
###end article-title 103
###begin title 104
Abbreviations
###end title 104
###begin p 105
anterior prostate
###end p 105
###begin p 106
benign prostatic hyperplasia
###end p 106
###begin p 107
cancer of the prostate
###end p 107
###begin p 108
embryonic stem
###end p 108
###begin p 109
hematoxylin and eosin
###end p 109
###begin p 110
hypoxanthine phosphoribosyltransferase
###end p 110
###begin p 111
immunohistochemistry
###end p 111
###begin p 112
monoclonal antibody
###end p 112
###begin p 113
###xml 0 5 <span type="species:ncbi:10090">mouse</span>
mouse embryonic fibroblast
###end p 113
###begin p 114
magnetic resonance imaging
###end p 114
###begin p 115
neomycin
###end p 115
###begin p 116
###xml 0 8 0 8 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Probasin</italic>
Probasin
###end p 116
###begin p 117
peripheral blood mononuclear cell
###end p 117
###begin p 118
phosphoinositide 3-kinase
###end p 118
###begin p 119
prostatic intraepithelial neoplasia
###end p 119
###begin p 120
phosphatidylinositol 3,4,5-trisphosphate
###end p 120
###begin p 121
phosphatase and tensin homolog deleted on chromosome 10
###end p 121
###begin p 122
RNA interference
###end p 122
###begin p 123
small interfering RNA
###end p 123
###begin p 124
Western blot
###end p 124
###begin title 125
Figures and Tables
###end title 125
###begin title 126
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 46 51 <span type="species:ncbi:10090">Mouse</span>
Production and Analysis of a Pten Hypomorphic Mouse Series
###end title 126
###begin p 127
###xml 3 3 3 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 47 48 47 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</italic>
###xml 64 66 64 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy</italic>
###xml 93 97 93 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 125 133 125 133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pbio.0000059-g003">Figure 3</xref>
(A) Schematic representation of the wild-type (+), hypomorphic (hy), and null (-) alleles of Pten. (For a detailed view, see Figure 3A.)
###end p 127
###begin p 128
###xml 38 42 38 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 95 99 95 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 55 60 <span type="species:ncbi:10090">mouse</span>
(B) Breeding scheme used to produce a Pten hypomorphic mouse series and predicted hierarchy of Pten expression levels.
###end p 128
###begin p 129
###xml 140 144 140 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
(C) WB analysis of MEF lysates from ten littermate primary cell cultures obtained from a single cross (indicated in [B]) confirms predicted Pten expression hierarchy in the hypomorphic series and inversely related Akt phosphorylation status (top), both verified by densitometric analysis and plotting of the Pten/actin and phospho-Akt/Akt ratios (bottom).
###end p 129
###begin p 130
###xml 117 121 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 190 194 190 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 202 206 202 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 222 226 222 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 226 230 226 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 332 336 332 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 349 353 349 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hprt</italic>
(D) MEF cDNA was amplified by semiquantitative PCR with exon 3 (forward) and exon 4-5 spanning (reverse) primers for Pten. Consistent with the concept of transcriptional interference at the Pten locus, Pten mRNA levels in Ptenhy/- MEFs are clearly below the level observed in heterozygosity. Lower panels show the quantification of Pten relative to Hprt amplification.
###end p 130
###begin title 131
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 41 46 <span type="species:ncbi:10090">Mouse</span>
Conditional Knockout of the Pten Gene in Mouse Prostate
###end title 131
###begin p 132
###xml 21 25 21 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 121 125 121 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 211 219 211 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EIIA-Cre</italic>
###xml 249 253 249 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 335 341 335 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PB-Cre</italic>
###xml 345 352 345 352 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PB-Cre4</italic>
###xml 608 612 608 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP</italic>
###xml 637 641 637 641 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 843 846 843 846 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 960 963 960 963 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 1027 1031 1027 1031 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1031 1035 1031 1035 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP</sup>
###xml 1068 1071 1068 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 1078 1081 1078 1081 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kpn</italic>
###xml 1088 1091 1088 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Bam</italic>
###xml 1103 1106 1103 1106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 220 225 <span type="species:ncbi:10090">mouse</span>
###xml 364 369 <span type="species:ncbi:10090">mouse</span>
(A) Map of wild-type Pten locus (top), targeting construct (second from top), predicted targeted locus (third from top), Pten locus after Cre-mediated excision of the Neo resistance cassette by crossing with an EIIA-Cre mouse (fourth from top), and Pten locus after Cre-mediated excision of the floxed exons 4 and 5 by crossing with a PB-Cre or PB-Cre4 transgenic mouse (bottom). The genomic sequence is depicted as a black line, with black boxes representing exons 4 and 5. Pink and yellow boxes represent the Neo resistance and the HSV thymidine kinase cassette (TK) and light blue triangles represent the loxP site, respectively. The Pten genomic fragments used as a probe for Southern blot analysis are shown (3' probe and probe 6.1). Solid arrows represent expected fragments following hybridization with the 3' probe upon digestion with EcoRI, and dashed arrows represent expected fragments following hybridization with the probe 6.1 upon digestion with XbaI. Locations of PCR primers to detect wild-type, floxed allele (PtenloxP), and deleted allele are shown. XbaI (X), KpnI (K), BamHI (B), and EcoRI (E) sites are shown.
###end p 132
###begin p 133
###xml 180 183 180 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Eco</italic>
###xml 391 399 391 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">EIIA-Cre</italic>
###xml 442 445 442 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 477 481 477 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 481 489 481 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP-neo</sup>
###xml 504 508 504 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 508 512 508 512 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP</sup>
###xml 710 713 710 713 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Xba</italic>
###xml 784 791 784 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PB-Cre4</italic>
###xml 797 801 797 801 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 801 807 801 807 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/+</sup>
###xml 820 824 820 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 824 830 824 830 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/+</sup>
###xml 888 892 888 892 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 892 898 892 898 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/+</sup>
###xml 926 930 926 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 930 933 930 933 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 963 967 963 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 967 976 967 976 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 1047 1051 1047 1051 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1051 1057 1051 1057 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxp/+</sup>
###xml 1070 1077 1070 1077 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PB-Cre4</italic>
###xml 1082 1086 1082 1086 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1086 1092 1086 1092 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/+</sup>
###xml 1144 1148 1144 1148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1148 1154 1148 1154 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/+</sup>
###xml 1174 1178 1174 1178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 1178 1181 1178 1181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 18 22 <span type="species:ncbi:10090">mice</span>
###xml 314 319 <span type="species:ncbi:10090">mouse</span>
###xml 357 362 <span type="species:ncbi:10090">mouse</span>
###xml 400 405 <span type="species:ncbi:10090">mouse</span>
###xml 591 596 <span type="species:ncbi:10090">mouse</span>
###xml 635 640 <span type="species:ncbi:10090">mouse</span>
###xml 668 673 <span type="species:ncbi:10090">mouse</span>
(B) Genotyping of mice. Lanes 1 and 2 show Southern blot analysis of ES cell clones with 3' probe of control (lanes 2) and recombined clones and #176 (lane 1) after digestion with EcoRI, showing a 6 kb wild-type band (WT) and a 2.5 kb targeted band (R). Lanes 3 and 4 (control) represent Southern blot analysis of mouse tail DNA of offspring by crossing F1 mouse generated from #176 with an EIIA-Cre mouse with probe 6.1 after digestion with XbaI, showing wild-type, targeted (PtenloxP-neo), and floxed (PtenloxP) locus bands. Lanes 5, 6 (control), and 7 represent Southern blot analysis of mouse tail DNA of offspring by crossing the mouse of lane 3 with a wild-type mouse with probe 6.1 after digestion with XbaI. Lanes 8-14 show PCR analysis of tail DNA of offspring by crossing a PB-Cre4 (+), PtenloxP/+ male with a PtenloxP/+ female with primers 1 and 2. Lanes 8, 9, and 14 indicate PtenloxP/+ , lanes 10 and 13 indicate Pten+/+,and lanes 11 and 12 indicate PtenloxP/loxP. Lanes 15-17 show PCR analysis of tail DNA of offspring by crossing a Ptenloxp/+ male with a PB-Cre4(+), PtenloxP/+ female with primers 1, 2, and 3. Lane 15 indicates PtenloxP/+, lane 16 indicates Pten+/+, and lane 17 indicates that the deleted allele exists in tail DNA of this offspring.
###end p 133
###begin p 134
###xml 73 77 73 77 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 103 112 103 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">loxP/loxP</sup>
###xml 139 145 139 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PB-Cre</italic>
###xml 165 172 165 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PB-Cre4</italic>
###xml 146 161 <span type="species:ncbi:10090">transgenic mice</span>
###xml 173 188 <span type="species:ncbi:10090">transgenic mice</span>
(C) Representation of crossing scheme used to generate prostate-specific Pten conditional mutants. PtenloxP/loxP mutants were crossed with PB-Cre transgenic mice or PB-Cre4 transgenic mice.
###end p 134
###begin title 135
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 4 8 4 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 9 13 <span type="species:ncbi:10090">Mice</span>
Ptenhy/- Mice Display Massive Hyperplasia and Invasive CaP
###end title 135
###begin p 136
###xml 3 3 3 3 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
(A) IHC on preneoplastic anterior prostate (AP) tissue of 2-mo-old littermate mice shows decreasing Pten protein levels in the hypomorphic series.
###end p 136
###begin p 137
(B) WB analysis of the prostate lobes from (A) is shown on the left and their quantification is shown on the right.
###end p 137
###begin p 138
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 15 19 15 19 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 280 284 280 284 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 284 287 284 287 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 291 295 291 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 295 298 295 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
###xml 299 303 <span type="species:ncbi:10090">mice</span>
(C) MRI of Ptenhy/- mice aged 6-8 mo shows pathologic structures (encircled by dashed lines) adjacent to seminal vesicles (SV) coinciding with displacement of the bladder (Bl), features typically associated with massive prostate tumors (right). These features were never found in Pten+/+ or Pten+/- mice (left).
###end p 138
###begin p 139
###xml 28 32 28 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 32 36 32 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 37 42 <span type="species:ncbi:10090">mouse</span>
(D) Macroscopic view of the Ptenhy/- mouse from (C) confirms massive enlargement of the AP lobes, but normal-sized seminal vesicles.
###end p 139
###begin p 140
###xml 68 72 68 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 72 76 72 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
(E) Quantification of WB analysis on AP lobe total lysates from the Ptenhy/- animal shown in (C) compared to preneoplastic AP of same genotype from (A) and (B), labeled 8 mo and 2 mo, respectively. Note that in the enlarged hyperplastic prostate, Pten protein expression is retained (levels are expressed relative to the corresponding wild-type animals).
###end p 140
###begin p 141
###xml 166 170 166 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 170 174 170 174 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 194 198 194 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 198 201 198 201 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 246 250 246 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 250 253 250 253 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
(F) Histopathology (H&E) of AP lesions at 8 mo reveals transition from low- to high-grade PIN and invasion (infiltration of stromal tissue is indicated by arrows) in Ptenhy/-, while age-matched Pten+/- tissue only shows hyperplastic features and Pten+/+ tissue is unaffected. Bars are 50 mum.
###end p 141
###begin title 142
###xml 29 33 29 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 77 82 <span type="species:ncbi:10090">Mouse</span>
Molecular Effects of Loss of Pten and Biological Comparison of All Generated Mouse Models
###end title 142
###begin p 143
(A) Ki-67 staining of AP lobe sections illustrates increasing proliferation with decreasing Pten levels (numbers are Ki-67-positive cells per 300 cells counted in percent; bars are 50 mum).
###end p 143
###begin p 144
###xml 81 85 81 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 85 88 85 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
(B) The phospho-Akt/Akt ratio is sharply increased in the prostates of 10-wk-old Ptenpc2 animals, as shown by densitometric quantification of WB analysis.
###end p 144
###begin p 145
###xml 244 248 244 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 248 251 248 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 269 274 <span type="species:ncbi:10090">mouse</span>
(C) AP staining with anti-phospho-Akt antibodies reveals strong plasma membrane localization of phospho-Akt and apparent reduction of p27 protein detection, whereas phospho-mTOR and phospho-threonine-FOXO3 antibodies show increased staining in Ptenpc2 versus wild-type mouse prostates. Bars are 50 mum.
###end p 145
###begin p 146
###xml 113 117 113 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 117 120 117 120 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 141 145 141 145 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 145 149 145 149 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 174 178 174 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 178 181 178 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 285 288 285 288 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 281 288 281 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>+/+</sup></italic>
###xml 296 299 296 299 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 292 299 292 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>+/&#8722;</sup></italic>
###xml 202 206 <span type="species:ncbi:10090">mice</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
(D) Kaplan-Meier curve showing prostate enlargement as visualized by MRI. Progressive rates of mass increase for Ptenpc2 (median age, 4 mo), Ptenhy/- (median age, 7 mo), and Ptenpc1 (median age, 16 mo) mice are found. In contrast, no prostatic size irregularities were detected in Pten+/+ or Pten+/- mice.
###end p 146
###begin p 147
###xml 203 206 203 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 199 206 199 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>pc1</sup></italic>
###xml 230 233 230 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 226 233 226 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>pc2</sup></italic>
###xml 257 261 257 261 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 253 261 253 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten<sup>hy/&#8722;</sup></italic>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 234 238 <span type="species:ncbi:10090">mice</span>
###xml 262 266 <span type="species:ncbi:10090">mice</span>
(E) Incidence of invasive CaP. Invasive CaP was defined as tumor cells disrupting the basal membrane of prostatic glands and growing into the surrounding stroma. Full penetrance was observed in both Ptenpc1 mice as well as in Ptenpc2 mice. In contrast, Ptenhy/- mice with a follow-up of more than 6 mo displayed only 25% incidence of invasive CaP.
###end p 147
###begin title 148
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 8 12 <span type="species:ncbi:10090">Mice</span>
Ptenpc2 Mice Develop Invasive CaP
###end title 148
###begin p 149
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 59 62 59 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 304 308 304 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 308 311 308 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 317 321 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 321 324 321 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 428 432 428 432 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 432 435 432 435 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 482 486 482 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 486 489 486 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 325 329 <span type="species:ncbi:10090">mice</span>
###xml 344 348 <span type="species:ncbi:10090">mice</span>
###xml 436 440 <span type="species:ncbi:10090">mice</span>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
(A) Histopathology analysis of wild-type, Ptenpc1, and Ptenpc2 mice prior to tumor onset. H&E-stained AP (top) shows the difference in both the morphology and proliferative rates of the prostatic epithelium in these two models. IHC staining with anti-Pten antibody (bottom) was carried out on wild-type, Ptenpc1, and Ptenpc2 mice. In wild-type mice, strong cytoplasmic staining was observed in epithelial cells (arrowheads). In Ptenpc1 mice, staining was generally weak, whereas in Ptenpc2 mice, staining was completely absent in the prostatic epithelium. Original magnification, 400x.
###end p 149
###begin p 150
###xml 74 78 74 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 78 81 78 81 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 151 155 151 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 155 158 155 158 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 162 166 162 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 166 169 166 169 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 352 356 352 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 356 359 356 359 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 400 404 400 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 404 407 404 407 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 469 473 469 473 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 473 476 473 476 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc1</sup>
###xml 723 727 723 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 727 730 727 730 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc2</sup>
###xml 82 86 <span type="species:ncbi:10090">mice</span>
###xml 170 174 <span type="species:ncbi:10090">mice</span>
###xml 408 412 <span type="species:ncbi:10090">mice</span>
###xml 477 481 <span type="species:ncbi:10090">mice</span>
###xml 731 735 <span type="species:ncbi:10090">mice</span>
(B) MRI (top) shows massive prostate tumor (surrounded by dashed line) in Ptenpc2 mice (at 6 mo) and no detectable difference between the prostates of Ptenpc1 or Pten+/+ mice (at 12 mo; arrowheads). Bladder (Bl) and seminal vesicles (SV) are indicated. Macroscopic view (second from top) of the same animals confirms massive enlargement of both APs in Ptenpc2 and reveals the slightly enlarged AP of Ptenpc1 mice (encircled). H&E staining (bottom) of the prostate from Ptenpc1 mice was characterized by multiple foci of PIN lesions and by the presence of prostatic adenocarcinoma. These lesions contained well-differentiated neoplastic cells and showed focal areas of invasion (arrowheads). H&E stainings of prostates from Ptenpc2 mice showed diffuse, invasive CaP with large, undifferentiated tumor cells growing into stromal areas.
###end p 150
###begin title 151
Pten Dose Affects Prostate Tumor Progression
###end title 151
###begin p 152
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 4 7 4 7 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 68 72 68 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 199 203 199 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 203 205 203 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">pc</sup>
###xml 304 311 304 311 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kip1&#8722;/&#8722;</sup>
###xml 301 311 301 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p27<sup>Kip1&#8722;/&#8722;</sup></italic>
###xml 503 507 503 507 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 670 674 670 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTEN</italic>
###xml 674 677 674 677 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 796 800 796 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Pten</italic>
###xml 800 804 800 804 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hy/&#8722;</sup>
###xml 804 804 804 804 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"/>
###xml 8 12 <span type="species:ncbi:10090">mice</span>
###xml 73 77 <span type="species:ncbi:10090">mice</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 312 316 <span type="species:ncbi:10090">mice</span>
###xml 371 376 <span type="species:ncbi:9606">human</span>
###xml 804 809 <span type="species:ncbi:10090">mouse</span>
Pten+/- mice develop hyperplasia, dysplasia, and low-grade PIN. Ptenhy/- mice develop at complete penetrance high-grade PIN at a young age (8-10 wk) and roughly 25% present invasive CaP around 8 mo. Ptenpc mice develop invasive CaP at complete penetrance. (See Discussion for a detailed description.) p27Kip1-/- mice, on the contrary, develop only BPH. Possibilities for human therapeutic intervention derived from our findings: in addition to inactivation of PI3K/AKT and mTOR enzymatic activities (in PTEN loss of heterozygosity condition), monitoring and elevation of PTEN expression levels of the remaining allele could not only prevent formation of PIN lesions (in PTEN+/- individuals), but could importantly also be used to counteract the progression to invasive phenotypes (as observed in Ptenhy/-mouse mutants).
###end p 152
###begin p 153
###xml 0 22 0 22 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Conflicts of Interest.</bold>
Conflicts of Interest. The authors have declared that no conflicts of interest exist.
###end p 153
###begin p 154
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Author Contributions.</bold>
Author Contributions. LCT, MN, ZAD, JAK, AD, AX, TVD, CC-C, and PPP conceived and designed the experiments. LCT, MN, ZAD, JAK, AD, and AX performed the experiments. LCT, MN, ZAD, JAK, AD, AX, ASBK, TVD, CC-C, and PPP analyzed the data. PR-B, NMG, TVD, and PPP contributed reagents/materials/analysis tools. LCT, MN, ZAD, and PPP wrote the paper.
###end p 154
###begin p 155
###xml 59 64 <span type="species:ncbi:9606">Human</span>
Academic Editor: Nicholas Hastie, Medical Research Council Human Genetics Unit, Western General Hospital
###end p 155

